Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,362 public trials 1,306 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

NCT06383403

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Topgraphy Health, Inc. Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 60 locations
View Trial Details
Completed

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

NCT01387555

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations
  • Moores University of California San Diego Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 38 locations
View Trial Details
Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

NCT05630820

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Centreville, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 171 locations
View Trial Details
Completed

A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

NCT04880031

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Central Research Associates Birmingham, Alabama, United States
  • Arizona Liver Health Chandler, Arizona, United States
  • Arizona Liver Health Peoria, Arizona, United States
  • Arizona Liver Health Tucson, Arizona, United States
View all 48 locations
View Trial Details
Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

NCT05630807

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Palo Alto, California, United States
View all 177 locations
View Trial Details
Completed

Combined Active Treatment in Type 2 Diabetes With NASH

NCT04639414

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +10 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Wiener Gesundheitsverbund, Klinik Landstraße Vienna, Austria
  • Medizinische Universität Wien Vienna, Austria
View all 26 locations
View Trial Details

Related conditions